O=C1C2=C(C(c3ccccc3)=NCCN2)C(c2cccc([N+](=O)[O-])c2)N1c1ccccc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?